Transurethral columnar balloon dilation of prostate for benign prostatic hyperplasia in middle-aged and high-risk patients
10.3969/j.issn.1671-8348.2017.32.017
- VernacularTitle:经尿道柱状水囊前列腺扩开术治疗中年及高危患者良性前列腺增生
- Author:
Yujie CHEN
1
;
Yunfeng HE
;
Yao ZHANG
;
Jun PU
;
Delin WANG
;
Xiaohou WU
Author Information
1. 重庆医科大学附属第一医院泌尿外科 400016
- Keywords:
benign prostatic hyperplasia;
transurethral columnar balloon dilation of prostate;
middle-aged patients;
high-risk patients
- From:
Chongqing Medicine
2017;46(32):4523-4525
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze and summarize the short-term clinical efficacy and surgical points of transurethral columnar balloon dilation of prostate for middle-aged and high-risk prostatic hyperplasia patients.Methods A total of 30 patients with benign prostatic hyperplasia(BPH) admitted to our department from March 2016 to December 2016 was retrospectively analyzed,including 9 middle-aged patients(less than 60 years old) and 21 high-risk patients with various underlying diseases(more than 80 years old).Transurethral columnar balloon dilation of prostate was adopted and performed in accordance with standard operation process.Results All 30 patients were operated successfully by extending their prostate at the direction of 12 o'clock to the fat layer with short operation time and less amount of bleeding.The complication rate was 6.7% (2/30),and the catheter was removed smoothly after the operation.After 1 month and 6 months follow-up,the international prostate symptom score(IPSS),quality of life score(QOL),maximum urinary flow rate(Qmax),residual urine(RUV) and other indicators were analyzed and were statistically significant(P<0.05).Conclusion Transurethral columnar balloon dilation of prostate is an effective and supplemental method for the treatment of BPH in middle-aged and high-risk patients.